UK Regulator Tests Using Consultancy Firms To Monitor GMP, GDP Compliance
Novel Approach Aims To Do Away With Frequent On-Site MHRA Inspections
Executive Summary
The MHRA is testing the feasibility of appointing eligible external consultants to be its eyes and ears when it comes to checking up on drug companies that have failed to meet good manufacturing and distribution practice requirements.